This Form 4 filing reports equity transactions by Ashoo Gupta, VP of Finance and Controller at 4D Molecular Therapeutics (FDMT), on December 20, 2025. The filing details the vesting of restricted stock units (RSUs) and related stock sales to cover tax obligations. Specifically, 866 RSUs vested and converted to common s...

Edward Oliver Gillespie, Chief Executive Officer and Director of ABUNDIA GLOBAL IMPACT GROUP, INC. (AGIG), reported two open market purchases of the company's common stock. On December 19, 2025, Gillespie acquired 8,461 shares at a weighted average price of $1.65 per share. Subsequently, on December 22, 2025, he purcha...

Matthew Henninger, a director at ABUNDIA GLOBAL IMPACT GROUP, INC., reported the purchase of 9,500 shares of common stock on December 19, 2025. The purchase was made through an open market transaction at a price of $1.74 per share. Following this transaction, Mr. Henninger directly owns 9,500 shares of the company's co...

This Form 4 filing reports that Troy Rudd, Chief Executive Officer and Director of AECOM, disposed of 600 shares of common stock on December 23, 2025, through a gift transaction (code G) at $0 per share. The shares were held indirectly through TN Rudd Investments, LP. Following this transaction, Rudd's total ownership ...

Jay C. Horgen, Chief Executive Officer and Director of AFFILIATED MANAGERS GROUP, INC., reported a disposition of 4,000 shares of Common Stock on December 23, 2025. The transaction, coded as a gift (G), resulted in zero proceeds. This is further detailed by footnote F1, indicating the shares were gifted to a charitable...

This filing details insider transactions for Daniel P. Amos, Chairman of the Board and CEO of AFLAC INC. On December 19, 2025, Mr. Amos disposed of 161,175 shares of Common Stock. Subsequently, on December 22, 2025, he acquired 240 shares and an additional 6 shares. Following these transactions, his post-transaction sh...

This filing details transactions made by Michael R. Winter, a director at ALLIENT INC (ALNT), on December 23, 2025. Mr. Winter disposed of 847 shares of Common Stock at a price of $55.56 per share, following which he owned 38,967 shares directly. Additionally, he acquired 847 shares of Common Stock at $55.85 per share,...

On December 22, 2025, THOMAS M. MONTGOMERY, SR. VP. - COMPTROLLER of AMETEK INC/ reported transactions involving the company's Common Stock and Stock Options. Montgomery acquired 6,388 shares of Common Stock at a price of $85.45 per share under a SARs plan, increasing his post-transaction holdings to 28,504 shares. In ...

This Form 4 filing details transactions made by Clark David Michael, Chief People Officer of AMICUS THERAPEUTICS, INC. (FOLD). On December 19, 2025, Mr. Michael disposed of 25,642 shares of Common Stock at a price of $14.1713 per share, leaving him with 245,690 shares. All transactions reported were executed under a Ru...

This filing details transactions of AMKOR TECHNOLOGY, INC. common stock by James J. Kim, a 10% owner. On December 19, 2025, Mr. Kim distributed 3,244,594 shares to the 2025 Grantor Retained Annuity Trust No. 1 of James J. Kim, retaining 61,645 shares. Additionally, on the same date, Mr. Kim's spouse, Agnes C. Kim, dist...

This filing details stock transactions by Agnes C. Kim, a member of a 10% owner group for AMKOR TECHNOLOGY, INC. (AMKR). On December 19, 2025, Ms. Kim distributed 2,538,000 shares of common stock to the 2025 Grantor Retained Annuity Trust No. 1 of Agnes C. Kim. Additionally, on the same date, her spouse, James J. Kim, ...

Susan Y. Kim, a director and 10% owner of Amkor Technology, Inc. (AMKR), reported transactions on December 19, 2025, and December 23, 2025. On December 19, 2025, 3,244,594 shares were distributed to the 2025 Grantor Retained Annuity Trust No. 1 of James J. Kim, and 2,538,000 shares were distributed to the 2025 Grantor ...

This filing details insider transactions for Daniel P. Amos, Chairman of the Board and CEO of AFLAC INC. On December 19, 2025, Mr. Amos disposed of 161,175 shares of Common Stock. Subsequently, on December 22, 2025, he acquired 240 shares and an additional 6 shares. Following these transactions, his post-transaction sh...

Eric Loumeau, Chief Legal Officer of ANAPTYSBIO, INC., reported transactions on December 22, 2025. Loumeau acquired 10,000 shares of Common Stock at $14.02 per share and disposed of 10,000 shares of Common Stock at $51.00 per share. These transactions were executed under a 10b5-1 trading plan. Additionally, Loumeau was...

Dennis Mulroy, Chief Financial Officer of ANAPTYSBIO, INC, reported transactions on December 22, 2025. Mulroy acquired 10,000 shares of common stock at $20.16 per share and disposed of 10,000 shares of common stock at $50.00 per share. These transactions were executed under a Rule 10b5-1 trading plan. Additionally, Mul...

John P. Schmid, a director at ANAPTYSBIO, INC, reported the sale of 11,068 shares of Common Stock on December 23, 2025. The sale was executed under the SpeakInc. Employee Ownership Plan (ESOP), with each share sold at a price of $51.00. Following this transaction, Mr. Schmid no longer directly holds any shares in the c...

Paul F. Lizzul, Chief Medical Officer of ANAPTYSBIO, INC, reported several transactions on December 22, 2025. Lizzul acquired 1,500 shares of Common Stock under the Company's ESPP at a price of $18.5 per share, increasing his post-transaction holdings to 28,467 shares. Concurrently, Lizzul disposed of 1,500 shares of C...

On December 23, 2025, Ware J. Anthony, a director at ANAPTYSBIO, INC., reported a sale of 3,900 shares of common stock. The transaction was executed at a price of $49.575 per share, resulting in a total sale value of $193,342.50. Following this transaction, Mr. Anthony directly owns 9,630 shares of the company's common...

This filing details a transaction involving Teri A. Little, SVP, CLO of APPLIED MATERIALS INC /DE. On December 19, 2025, Ms. Little disposed of 15,472 shares of Common Stock at a price of $256.41 per share. This transaction, marked with code "F", resulted in a post-transaction ownership of 91,949 shares. The shares wit...

Nalamasu Omkaram, Senior Vice President, CTO of APPLIED MATERIALS INC /DE, reported a transaction on 2025-12-19 involving 20,307 shares of Common Stock. These shares were disposed of at a price of $256.41 per share. The transaction was automatically exempt under Rule 16b-3 to cover tax withholding obligations upon vest...

Raja Prabu G., President of Semi. Products Grp. at APPLIED MATERIALS INC /DE (AMAT), reported a disposition of 33,406 shares of Common Stock on December 19, 2025, at a price of $256.41 per share. This transaction was part of a tax withholding obligation upon vesting of equity awards, as indicated by footnote F1. Follow...

This filing details a transaction by Hill Brice, SVP, CFO of APPLIED MATERIALS INC /DE, on December 19, 2025. Brice disposed of 28,062 shares of Common Stock at a price of $256.41 per share. This transaction was made to cover tax withholding obligations upon the vesting of equity awards, as indicated by footnote F1. Fo...

This filing details a transaction by Timothy M. Deane, SVP, Applied Global Services at Applied Materials Inc. On December 19, 2025, Mr. Deane disposed of 16,465 shares of Common Stock at a price of $256.41 per share. This disposal was to cover tax withholding obligations upon the vesting of equity awards, as indicated ...

This filing details a transaction by Gary E. Dickerson, President and CEO of APPLIED MATERIALS INC /DE. On December 19, 2025, Mr. Dickerson disposed of 130,843 shares of Common Stock at a price of $256.41 per share. This transaction was made to cover tax withholding obligations upon the vesting of equity awards, as ind...

Raymond F. O'Conor, a director at ARROW FINANCIAL CORP, reported transactions on December 19, 2025. He acquired 1093 shares of Common Stock through the exercise of a Director Stock Option at a price of $27.04 per share. This option, which vested in four equal annual installments starting January 27, 2022, had an exerci...